Aperçu gratuit du livre Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Obtenez 58 points et profitez d’un rabais additionnel avec plum+. En savoir plus.
Description
Convient aux personnes de
Langue
anglais
Pages
248
Publié par:1KG Limited
Dimensions à l’expédition: 9" H x 6" W x 1" L
ISBN: 9781334766749
Étape de vie: null
Vous aimerez peut-être aussi
Cotes et évaluations
bvseo_sdk, dw_cartridge, 18.2.0, p_sdk_3.2.0
CLOUD, getReviews, 6ms
reviews, product
bvseo-msg: Unsuccessful GET. status = 'ERROR', msg = 'Not Found.'; Unsuccessful GET. status = 'ERROR', msg = 'Not Found.';
Évaluation éditoriale
Auteur
D’autres ont aussi acheté
Choix du format
DÉTAILS DE LA PROMOTION
* Offre en vigueur du 13 janvier au 2 mars 2025 dans les magasins au Canada et à indigo.ca, avec tout achat d'au moins 30 $ d’articles admissibles en stock, avant les taxes et après les rabais applicables au cours d’une même transaction. L’offre ne s’applique pas aux achats antérieurs et ne peut être jumelée à aucune autre offre.
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit/fr-ca/pricing-of-drugs-codeveloped-by-federal-laboratories-and-private-companies-hearing-before-the-subcommittee-on-regulation-business-opportunities-and-technology-of-the-commit/5D7C80F3-4359-406D-AB71-092DAD0B8D15.html5D7C80F3-4359-406D-AB71-092DAD0B8D15
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Pricing Of Drugs Codeveloped By Federal Laboratories And Private Companies: Hearing Before The Subcommittee On Regulation, Business Opportunities, And Technology Of The Commit
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Fi